drugset / Trial / NCT07591883

Spatiotemporal Evolution of Traditional Chinese Medicine Mechanisms in Acute Ischemic Stroke Treated With Dengzhan Xixin and Dengzhan Shengmai

NCT07591883 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

To integrate large-scale RCT data on clinical symptoms, TCM syndromes, prognosis, and multi-omics profiles, construct a spatiotemporal dynamic network for disease-syndrome evolution of acute ischemic stroke (AIS) in the acute and recovery phases, evaluate the efficacy and safety of sequential treatment with Erigeron breviscapus-Dengzhan Shengmai for AIS, and provide evidence for precise syndrome differentiation and individualized therapy.Secondary Objective:To investigate the optimal time window and key intervention targets of sequential treatment with Erigeron breviscapus-Dengzhan Shengmai for AIS.

Timeline

Start
2026-06-01
Primary completion
2029-07-30
Completion
2029-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Dengzhan Shengmai Traditional medicine (herbal / TCM) 0.36 g Oral
Subject Erigeron breviscapus Unknown 40 ml Intravenous

Indications